Literature DB >> 18762808

Smad7 is inactivated through a direct physical interaction with the LIM protein Hic-5/ARA55.

H Wang1, K Song, T L Krebs, J Yang, D Danielpour.   

Abstract

We recently reported that hydrogen peroxide-inducible clone-5 (Hic-5, also named androgen receptor-associated protein 55) can bind to the transforming growth factor-beta (TGF-beta)-signaling regulator Smad3, thereby inhibiting certain Smad3-dependent TGF-beta responses. We now show that Hic-5 can also control TGF-beta responses through an alternative mechanism involving Smad7, a key negative regulator of TGF-beta signaling. Hic-5 binds directly to Smad7. This interaction requires the LIM3 domain of Hic-5, and enhances TGF-beta signaling through causing loss of Smad7 protein but not mRNA. Enforced expression of Hic-5 reverses the ability of Smad7 to suppress TGF-beta-induced phosphorylation of Smads 2 and 3 and activation of the plasminogen activator inhibitor-1 promoter (in NRP-154 and PC3 prostate carcinoma and WPMY-1 prostate myofibroblast cell lines). Lentiviral-mediated small-hairpin RNA silencing of endogenous Hic-5 reduced TGF-beta responses in PC3 and WPMY-1 cells. Further work suggests that the level of Smad7 is modulated by its physical interaction with Hic-5 and targeted to a degradation pathway not likely to be proteasomal. Our findings support that Hic-5 functions as a cell-type-specific activator of TGF-beta signaling through its ability to physically interact with and neutralize Smad7.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18762808      PMCID: PMC3285457          DOI: 10.1038/onc.2008.291

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  59 in total

1.  Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference.

Authors:  Maciej Wiznerowicz; Didier Trono
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

2.  The type II TGF-beta receptor signals diverse responses in cooperation with the type I receptor.

Authors:  J L Wrana; J Cárcamo; L Attisano; S Cheifetz; A Zentella; F López-Casillas; J Massagué
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1992

3.  Inactivation of androgen receptor coregulator ARA55 inhibits androgen receptor activity and agonist effect of antiandrogens in prostate cancer cells.

Authors:  Mujib M Rahman; Hiroshi Miyamoto; Henry Lardy; Chawnshang Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-16       Impact factor: 11.205

4.  Arkadia amplifies TGF-beta superfamily signalling through degradation of Smad7.

Authors:  Daizo Koinuma; Masahiko Shinozaki; Akiyoshi Komuro; Kouichiro Goto; Masao Saitoh; Aki Hanyu; Masahito Ebina; Toshihiro Nukiwa; Keiji Miyazawa; Takeshi Imamura; Kohei Miyazono
Journal:  EMBO J       Date:  2003-12-15       Impact factor: 11.598

5.  Insulin-like growth factor-I inhibits transcriptional responses of transforming growth factor-beta by phosphatidylinositol 3-kinase/Akt-dependent suppression of the activation of Smad3 but not Smad2.

Authors:  Kyung Song; Susan C Cornelius; Michael Reiss; David Danielpour
Journal:  J Biol Chem       Date:  2003-07-21       Impact factor: 5.157

Review 6.  TGF-beta receptors.

Authors:  J Massagué; J Andres; L Attisano; S Cheifetz; F López-Casillas; M Ohtsuki; J L Wrana
Journal:  Mol Reprod Dev       Date:  1992-06       Impact factor: 2.609

7.  Negative regulation of transforming growth factor-beta (TGF-beta) signaling by WW domain-containing protein 1 (WWP1).

Authors:  Akiyoshi Komuro; Takeshi Imamura; Masao Saitoh; Yoko Yoshida; Takao Yamori; Kohei Miyazono; Keiji Miyazawa
Journal:  Oncogene       Date:  2004-09-09       Impact factor: 9.867

Review 8.  Plasminogen activator inhibitor 1 (PAI-1): in vitro activities and clinical relevance.

Authors:  Anton J G Horrevoets
Journal:  Br J Haematol       Date:  2004-04       Impact factor: 6.998

9.  Development and characterization of nontumorigenic and tumorigenic epithelial cell lines from rat dorsal-lateral prostate.

Authors:  D Danielpour; K Kadomatsu; M A Anzano; J M Smith; M B Sporn
Journal:  Cancer Res       Date:  1994-07-01       Impact factor: 12.701

Review 10.  Plasminogen activator inhibitor-I and tumour growth, invasion, and metastasis.

Authors:  Michelle K V Durand; Julie S Bødker; Anni Christensen; Daniel M Dupont; Martin Hansen; Jan K Jensen; Signe Kjelgaard; Lisa Mathiasen; Katrine E Pedersen; Sune Skeldal; Troels Wind; Peter A Andreasen
Journal:  Thromb Haemost       Date:  2004-03       Impact factor: 5.249

View more
  28 in total

1.  Tumor microenvironmental signaling elicits epithelial-mesenchymal plasticity through cooperation with transforming genetic events.

Authors:  Damian J Junk; Rocky Cipriano; Benjamin L Bryson; Hannah L Gilmore; Mark W Jackson
Journal:  Neoplasia       Date:  2013-09       Impact factor: 5.715

2.  Hic-5 as a regulator of endothelial cell morphology and connective tissue growth factor gene expression.

Authors:  Claudiu Komorowsky; Jana Samarin; Margot Rehm; Diego Guidolin; Margarete Goppelt-Struebe
Journal:  J Mol Med (Berl)       Date:  2010-03-24       Impact factor: 4.599

3.  Hic-5 is required for myofibroblast differentiation by regulating mechanically dependent MRTF-A nuclear accumulation.

Authors:  Scott D Varney; Courtney B Betts; Rui Zheng; Lei Wu; Boris Hinz; Jiliang Zhou; Livingston Van De Water
Journal:  J Cell Sci       Date:  2016-01-12       Impact factor: 5.285

4.  Transforming growth factor-β1-induced transcript 1 protein, a novel marker for smooth muscle contractile phenotype, is regulated by serum response factor/myocardin protein.

Authors:  Xiaobo Wang; Guoqing Hu; Courtney Betts; Erin Yund Harmon; Rebecca S Keller; Livingston Van De Water; Jiliang Zhou
Journal:  J Biol Chem       Date:  2011-10-08       Impact factor: 5.157

5.  DHT selectively reverses Smad3-mediated/TGF-beta-induced responses through transcriptional down-regulation of Smad3 in prostate epithelial cells.

Authors:  Kyung Song; Hui Wang; Tracy L Krebs; Bingcheng Wang; Thomas J Kelley; David Danielpour
Journal:  Mol Endocrinol       Date:  2010-08-25

Review 6.  The pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-beta in normal and malignant mammary epithelial cells.

Authors:  Molly A Taylor; Jenny G Parvani; William P Schiemann
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-05-15       Impact factor: 2.673

7.  Mutant p53 promotes tumor cell malignancy by both positive and negative regulation of the transforming growth factor β (TGF-β) pathway.

Authors:  Lei Ji; Jinjin Xu; Jian Liu; Ali Amjad; Kun Zhang; Qingwu Liu; Lei Zhou; Jianru Xiao; Xiaotao Li
Journal:  J Biol Chem       Date:  2015-03-12       Impact factor: 5.157

8.  The effect of transforming growth factor-beta1 on nasopharyngeal carcinoma cells: insensitive to cell growth but functional to TGF-beta/Smad pathway.

Authors:  Jian Xiao; Qi Xiang; Ye-Chen Xiao; Zhi-Jian Su; Zhi-Feng Huang; Qi-Hao Zhang; Yi Tan; Xiao-Kun Li; Ya-Dong Huang
Journal:  J Exp Clin Cancer Res       Date:  2010-04-23

9.  CDKN2B Regulates TGFβ Signaling and Smooth Muscle Cell Investment of Hypoxic Neovessels.

Authors:  Vivek Nanda; Kelly P Downing; Jianqin Ye; Sophia Xiao; Yoko Kojima; Joshua M Spin; Daniel DiRenzo; Kevin T Nead; Andrew J Connolly; Sonny Dandona; Ljubica Perisic; Ulf Hedin; Lars Maegdefessel; Jessie Dalman; Liang Guo; XiaoQing Zhao; Frank D Kolodgie; Renu Virmani; Harry R Davis; Nicholas J Leeper
Journal:  Circ Res       Date:  2015-11-23       Impact factor: 17.367

10.  Paxillin family of focal adhesion adaptor proteins and regulation of cancer cell invasion.

Authors:  Kyle M Alpha; Weiyi Xu; Christopher E Turner
Journal:  Int Rev Cell Mol Biol       Date:  2020-08-06       Impact factor: 6.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.